We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$2.66B
AUM Growth
+$310M
Cap. Flow
-$54M
Cap. Flow %
-2.03%
Top 10 Hldgs %
18.8%
Holding
435
New
70
Increased
72
Reduced
125
Closed
75

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$69.2M
2
CSX icon
CSX Corp
CSX
+$32.5M
3
BABA icon
Alibaba
BABA
+$31.6M
4
CTAS icon
Cintas
CTAS
+$26.2M
5
INTU icon
Intuit
INTU
+$21.7M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$26M
2
UNH icon
UnitedHealth
UNH
+$26M
3
EOG icon
EOG Resources
EOG
+$24.5M
4
JBHT icon
JB Hunt Transport Services
JBHT
+$23.8M
5
CAT icon
Caterpillar
CAT
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 21.6%
2 Healthcare 16.93%
3 Consumer Discretionary 13.71%
4 Industrials 12.39%
5 Energy 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSTG
151
DELISTED
NanoString Technologies, Inc.
NSTG
$5.53M 0.21%
+231,025
New +$5.31M
DORM icon
152
Dorman Products
DORM
$3.72B
$5.51M 0.21%
62,530
-935
-1% -$81.3K
ARRY
153
DELISTED
Array Biopharma Inc
ARRY
$5.37M 0.2%
+220,116
New +$4.58M
WWD icon
154
Woodward
WWD
$18.9B
$5.2M 0.2%
+54,836
New +$4.85M
AGX icon
155
Argan
AGX
$5.45B
$5.14M 0.19%
+102,819
New +$4.63M
CTRA
156
DELISTED
Coterra Energy
CTRA
$5.1M 0.19%
195,300
+110,530
+130% +$2.77M
VRTX icon
157
Vertex Pharmaceuticals
VRTX
$130B
$4.93M 0.19%
26,830
– –
KMI icon
158
Kinder Morgan
KMI
$68.5B
$4.8M 0.18%
239,890
– –
COP icon
159
ConocoPhillips
COP
$170B
$4.77M 0.18%
71,460
-27,000
-27% -$1.82M
GBT
160
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.74M 0.18%
89,545
-1,470
-2% -$72.2K
RDS.A
161
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$4.58M 0.17%
73,200
– –
SPSC icon
162
SPS Commerce
SPSC
$2.95B
$4.57M 0.17%
86,230
-6,648
-7% -$326K
VLO icon
163
Valero Energy
VLO
$114B
$4.57M 0.17%
53,850
+41,580
+339% +$3.44M
AGS
164
DELISTED
PlayAGS
AGS
$4.54M 0.17%
189,921
-3,474
-2% -$85.8K
TDC icon
165
Teradata
TDC
$2.73B
$4.48M 0.17%
+102,721
New +$4.61M
MRO
166
DELISTED
Marathon Oil Corporation
MRO
$4.33M 0.16%
259,300
-21,980
-8% -$359K
NVCR icon
167
NovoCure
NVCR
$1.88B
$4.26M 0.16%
88,358
-159,155
-64% -$7.66M
BEAT
168
DELISTED
BioTelemetry, Inc.
BEAT
$4.09M 0.15%
65,278
-150,033
-70% -$10.3M
CQP icon
169
Cheniere Energy
CQP
$31.8B
$4.04M 0.15%
96,360
– –
EOG icon
170
EOG Resources
EOG
$80.6B
$4.04M 0.15%
42,430
-256,851
-86% -$24.5M
RARE icon
171
Ultragenyx Pharmaceutical
RARE
$1.29B
$3.97M 0.15%
+57,185
New +$3.27M
NICE icon
172
Nice
NICE
$6.09B
$3.86M 0.15%
31,540
+4,540
+17% +$512K
B
173
Barrick Mining
B
$70.3B
$3.79M 0.14%
276,340
+183,840
+199% +$2.38M
CMG icon
174
Chipotle Mexican Grill
CMG
$44.1B
$3.75M 0.14%
264,250
-5,500
-2% -$63.8K
TTE icon
175
TotalEnergies
TTE
$206B
$3.72M 0.14%
66,805
+43,265
+184% +$2.41M
5 6
7
8 9

Similar funds

MSC
MUFG Securities (Canada) New York $3.71B AUM 38.19% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.7B AUM 39.18% 1-Year Est. Return
OH
Osiris Holdings Monaco $3.72B AUM
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.7B AUM 32.64% 1-Year Est. Return
MCM
MKP Capital Management New York $3.7B AUM 23.18% 1-Year Est. Return

Castleark Management's Q1 2019 Portfolio in Review

As of Q1 2019, Castleark Management held 435 positions worth $2.66B, up 13% from $2.35B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Castleark Management's Q1 2019 filing shows 70 new, 72 increased, 125 reduced and 75 closed positions. Its largest new stake was CSX Corp: 1,401,555 shares worth $35M. The largest sale was Eli Lilly, an estimated $26M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Castleark Management's largest Q1 2019 buy was CSX Corp: 1,401,555 shares worth $35M.
  • Castleark Management added most to iShares MSCI Emerging Markets ETF in Q1 2019, an estimated $69.2M increase.
  • Castleark Management's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $26M.
  • Castleark Management fully exited Align Technology in Q1 2019, selling an estimated $14M.
  • Castleark Management's ten largest holdings make up 19% of its $2.66B portfolio in Q1 2019.
  • Castleark Management opened 70 new positions and closed 75 in Q1 2019.
  • Castleark Management's portfolio value rose 13% quarter-over-quarter to $2.66B.

Based on Castleark Management's 13F filing for Q1 2019, filed 14 May 2019.